Skip to main content

Atlas Lithium Corp

For the period ended Dec 31, 2024. Filed Mar 14, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Mar 14, 2025

ATLX$1.69+3.0%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Consolidated Statement of Stockholders’ Equity

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

Series A Preferred Stock · Series D Preferred Stock · Common Stock · Additional Paid-in · Accumulated Other Comprehensive · Cumulative Adjustment of the Valuation of Fin. · Accumulated · Noncontrolling · Total Stockholders’ Equity
Shares · Value · Shares · Value · Shares · Value · Capital · Loss · Instruments · Deficit · Interests · (Deficit)
Balance, December 31, 20221$1214,006$2145,110,014$5,111$62,063,367$(6,636)$-$(60,391,694)$(212,239)$1,458,124
Issuance of common stock in connection with sales made under private offerings----2,449,4672,44933,147,014----33,149,463
Issuance of common stock in connection with purchase of mining rights----77,24077749,923----750,000
Exercise of options into Series D preferred stock--108,000108--2,934----3,042
Conversion of Convertible Preferred D stock into Common Stock--(322,006)(322)4,293,4094,293-----3,971
Other changes in Noncontrolling interest---------(1,662,154)1,662,154-
Exercise of warrants----446,948447(447)-----
Exercise of option issued----386,503386(386)-----
Stock based compensation------14,233,573---312,84214,546,415
Change in foreign currency translation-------(132,193)--(113,714)(245,906)
Net loss---------(40,768,275)(1,221,741)(41,990,016)
Balance, December 31, 20231$1-$-12,763,581$12,764$110,195,978$(138,829)$-$(102,822,123)$427,302$7,675,093
Series A Preferred Stock · Series D Preferred Stock · Common Stock · Additional Paid-in · Accumulated Other Comprehensive · Cumulative Adjustment of the Valuation of Fin. · Accumulated · Noncontrolling · Total Stockholders’ Equity
Shares · Value · Shares · Value · Shares · Value · Capital · Loss · Instruments · Deficit · Interests · (Deficit)
Balance, December 31, 20231$1-$-12,763,581$12,764$110,195,978$(138,829)$-$(102,822,123)$427,302$7,675,093
Issuance of common stock in connection with sales made under private offerings----2,062,9732,06331,313,878---1,600,70032,916,641
Issuance of common stock in exchange for consulting, professional and other services----36,00036398,977----399,013
Exercise of warrants1,115,8621,1163,000----4,116
Stock based compensation----36,3263624,199,083---1,788,32125,987,440
Adjustment of the Valuation of Fin. Instruments--------(278,820)--(278,820)
Other changes in Noncontrolling interest---------652,979(652,979)-
Change in foreign currency translation-------(41,161)--(237,859)(279,020)
Net loss---------(42,241,196)(2,172,026)(44,413,222)
Balance, December 31, 20241$1-$-16,014,742$16,015$166,110,916$(179,990)$(278,820)$(144,410,340)$753,459$22,011,241
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.